JP2013523705A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013523705A5 JP2013523705A5 JP2013501932A JP2013501932A JP2013523705A5 JP 2013523705 A5 JP2013523705 A5 JP 2013523705A5 JP 2013501932 A JP2013501932 A JP 2013501932A JP 2013501932 A JP2013501932 A JP 2013501932A JP 2013523705 A5 JP2013523705 A5 JP 2013523705A5
- Authority
- JP
- Japan
- Prior art keywords
- ester
- physiologically acceptable
- formula
- acceptable salt
- alkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000002148 esters Chemical class 0.000 claims 14
- 150000003839 salts Chemical class 0.000 claims 14
- 235000000346 sugar Nutrition 0.000 claims 14
- 238000000034 method Methods 0.000 claims 12
- 150000001875 compounds Chemical class 0.000 claims 9
- 229930006000 Sucrose Natural products 0.000 claims 8
- 239000005720 sucrose Substances 0.000 claims 8
- 239000002671 adjuvant Substances 0.000 claims 6
- 125000000217 alkyl group Chemical group 0.000 claims 6
- 150000008163 sugars Chemical class 0.000 claims 6
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims 5
- AZDRQVAHHNSJOQ-UHFFFAOYSA-N alumane Chemical class [AlH3] AZDRQVAHHNSJOQ-UHFFFAOYSA-N 0.000 claims 5
- FFDGPVCHZBVARC-UHFFFAOYSA-N N,N-dimethylglycine Chemical compound CN(C)CC(O)=O FFDGPVCHZBVARC-UHFFFAOYSA-N 0.000 claims 4
- 239000000427 antigen Substances 0.000 claims 4
- 102000036639 antigens Human genes 0.000 claims 4
- 108091007433 antigens Proteins 0.000 claims 4
- 238000004108 freeze drying Methods 0.000 claims 3
- 238000007710 freezing Methods 0.000 claims 3
- 230000008014 freezing Effects 0.000 claims 3
- 229910052739 hydrogen Inorganic materials 0.000 claims 3
- 239000001257 hydrogen Substances 0.000 claims 3
- 239000011159 matrix material Substances 0.000 claims 3
- 239000000203 mixture Substances 0.000 claims 3
- 239000000843 powder Substances 0.000 claims 3
- 239000007787 solid Substances 0.000 claims 3
- 125000000185 sucrose group Chemical group 0.000 claims 3
- 229960005486 vaccine Drugs 0.000 claims 3
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical group OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 claims 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 2
- 229930195725 Mannitol Natural products 0.000 claims 2
- MUPFEKGTMRGPLJ-RMMQSMQOSA-N Raffinose Natural products O(C[C@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@@H](O[C@@]2(CO)[C@H](O)[C@@H](O)[C@@H](CO)O2)O1)[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 MUPFEKGTMRGPLJ-RMMQSMQOSA-N 0.000 claims 2
- MUPFEKGTMRGPLJ-UHFFFAOYSA-N UNPD196149 Natural products OC1C(O)C(CO)OC1(CO)OC1C(O)C(O)C(O)C(COC2C(C(O)C(O)C(CO)O2)O)O1 MUPFEKGTMRGPLJ-UHFFFAOYSA-N 0.000 claims 2
- 239000003708 ampul Substances 0.000 claims 2
- 239000007864 aqueous solution Substances 0.000 claims 2
- 239000007900 aqueous suspension Substances 0.000 claims 2
- 150000001720 carbohydrates Chemical class 0.000 claims 2
- 108700003601 dimethylglycine Proteins 0.000 claims 2
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 claims 2
- 239000000594 mannitol Substances 0.000 claims 2
- 235000010355 mannitol Nutrition 0.000 claims 2
- 229940078490 n,n-dimethylglycine Drugs 0.000 claims 2
- 239000000546 pharmaceutical excipient Substances 0.000 claims 2
- MUPFEKGTMRGPLJ-ZQSKZDJDSA-N raffinose Chemical group O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O2)O)O1 MUPFEKGTMRGPLJ-ZQSKZDJDSA-N 0.000 claims 2
- FSYKKLYZXJSNPZ-UHFFFAOYSA-N sarcosine Chemical compound C[NH2+]CC([O-])=O FSYKKLYZXJSNPZ-UHFFFAOYSA-N 0.000 claims 2
- 239000004471 Glycine Substances 0.000 claims 1
- CMUNUTVVOOHQPW-LURJTMIESA-N L-proline betaine Chemical compound C[N+]1(C)CCC[C@H]1C([O-])=O CMUNUTVVOOHQPW-LURJTMIESA-N 0.000 claims 1
- RWRDLPDLKQPQOW-UHFFFAOYSA-N Pyrrolidine Chemical group C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 claims 1
- 108010077895 Sarcosine Proteins 0.000 claims 1
- UQZIYBXSHAGNOE-USOSMYMVSA-N Stachyose Natural products O(C[C@H]1[C@@H](O)[C@H](O)[C@H](O)[C@@H](O[C@@]2(CO)[C@H](O)[C@@H](O)[C@@H](CO)O2)O1)[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@H](CO[C@@H]2[C@@H](O)[C@@H](O)[C@@H](O)[C@H](CO)O2)O1 UQZIYBXSHAGNOE-USOSMYMVSA-N 0.000 claims 1
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 claims 1
- ILRRQNADMUWWFW-UHFFFAOYSA-K aluminium phosphate Chemical group O1[Al]2OP1(=O)O2 ILRRQNADMUWWFW-UHFFFAOYSA-K 0.000 claims 1
- 125000004429 atom Chemical group 0.000 claims 1
- 239000002775 capsule Substances 0.000 claims 1
- MRUAUOIMASANKQ-UHFFFAOYSA-N cocamidopropyl betaine Chemical compound CCCCCCCCCCCC(=O)NCCC[N+](C)(C)CC([O-])=O MRUAUOIMASANKQ-UHFFFAOYSA-N 0.000 claims 1
- 229940073507 cocamidopropyl betaine Drugs 0.000 claims 1
- 150000002431 hydrogen Chemical class 0.000 claims 1
- 230000035479 physiological effects, processes and functions Effects 0.000 claims 1
- 239000000243 solution Substances 0.000 claims 1
- UQZIYBXSHAGNOE-XNSRJBNMSA-N stachyose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO[C@@H]3[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O3)O)O2)O)O1 UQZIYBXSHAGNOE-XNSRJBNMSA-N 0.000 claims 1
- 150000005846 sugar alcohols Chemical class 0.000 claims 1
- 239000000725 suspension Substances 0.000 claims 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1005518.4A GB201005518D0 (en) | 2010-03-31 | 2010-03-31 | Preservation of alum-adjuvanted vaccines |
| GB1005522.6 | 2010-03-31 | ||
| GBGB1005522.6A GB201005522D0 (en) | 2010-03-31 | 2010-03-31 | Method for preserving alum-adjuvanted vaccines |
| GB1005518.4 | 2010-03-31 | ||
| PCT/GB2011/000497 WO2011121305A2 (en) | 2010-03-31 | 2011-03-31 | Method for preserving alum adjuvants and alum-adjuvanted vaccines |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2013523705A JP2013523705A (ja) | 2013-06-17 |
| JP2013523705A5 true JP2013523705A5 (cg-RX-API-DMAC7.html) | 2014-04-24 |
| JP6023696B2 JP6023696B2 (ja) | 2016-11-09 |
Family
ID=43971221
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013501932A Active JP6023696B2 (ja) | 2010-03-31 | 2011-03-31 | ミョウバンアジュバントおよびミョウバンアジュバント化ワクチンの保存方法 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US9101607B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP2552410B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP6023696B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR101819250B1 (cg-RX-API-DMAC7.html) |
| CN (1) | CN102892409B (cg-RX-API-DMAC7.html) |
| AU (1) | AU2011234268B2 (cg-RX-API-DMAC7.html) |
| BR (1) | BR112012025044A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2795050C (cg-RX-API-DMAC7.html) |
| DK (1) | DK2552410T3 (cg-RX-API-DMAC7.html) |
| ES (1) | ES2708989T3 (cg-RX-API-DMAC7.html) |
| GB (1) | GB2499480A (cg-RX-API-DMAC7.html) |
| HU (1) | HUE042330T2 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2011121305A2 (cg-RX-API-DMAC7.html) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2617921T3 (es) | 2010-03-31 | 2017-06-20 | Stabilitech Ltd. | Excipientes para estabilizar partículas virales |
| CN102892424B (zh) | 2010-03-31 | 2015-04-01 | 稳定性科技有限公司 | 病毒颗粒的稳定 |
| GB201117233D0 (en) | 2011-10-05 | 2011-11-16 | Stabilitech Ltd | Stabilisation of polypeptides |
| WO2015157637A1 (en) * | 2014-04-11 | 2015-10-15 | Surmodics Ivd, Inc. | Compositions and methods for in vitro diagnostic tests including zwitterionic solubilization reagent |
| GB201406569D0 (en) * | 2014-04-11 | 2014-05-28 | Stabilitech Ltd | Vaccine compositions |
| GB2562241B (en) * | 2017-05-08 | 2022-04-06 | Stabilitech Biopharma Ltd | Vaccine compositions |
| AR111760A1 (es) * | 2017-05-19 | 2019-08-14 | Novartis Ag | Compuestos y composiciones para el tratamiento de tumores sólidos mediante administración intratumoral |
| CN113750228B (zh) * | 2021-09-25 | 2024-02-20 | 大连理工大学 | 一种冷冻保护剂在铝佐剂中的应用 |
Family Cites Families (62)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3927208A (en) | 1973-05-14 | 1975-12-16 | Rit Rech Ind Therapeut | Live bovine adenovirus vaccines, preparation thereof and method of vaccination using them |
| US4631189A (en) | 1980-03-10 | 1986-12-23 | Da Vinci Laboratories, a division of FoodScience Corporation | N,N-dimethylglycine and use in immune response |
| JPS6013718A (ja) * | 1983-07-05 | 1985-01-24 | Chemo Sero Therapeut Res Inst | Ｂ型肝炎ワクチン |
| JPS60193925A (ja) | 1984-03-13 | 1985-10-02 | Chemo Sero Therapeut Res Inst | 凍結乾燥製剤化ワクチン |
| US4808700A (en) | 1984-07-09 | 1989-02-28 | Praxis Biologics, Inc. | Immunogenic conjugates of non-toxic E. coli LT-B enterotoxin subunit and capsular polymers |
| JPS61189228A (ja) | 1985-02-19 | 1986-08-22 | Nippon Sekijiyuujishiya | 血液凝固第８因子製剤の製法 |
| US4950596A (en) | 1985-03-04 | 1990-08-21 | The Dow Chemical Company | Stabilization of intracellular enzymes |
| JPS6238173A (ja) | 1985-08-13 | 1987-02-19 | 三菱レイヨン株式会社 | 抗血液凝固剤 |
| US5169758A (en) | 1986-05-02 | 1992-12-08 | Boehringer Mannheim Gmbh | Stabilized, NAD(P)H-dependent, soluble nitrate reductase, a process for the preparation thereof and a reagent containing it |
| NZ221306A (en) | 1986-08-15 | 1990-02-26 | Commw Scient Ind Res Org | 2-component immunoadjuvant comprising a mycobacterial free immunoadjuvant oil and a polycationic polyelectrolyte immunoadjuvant and vaccines thereof |
| ES2044941T5 (es) * | 1987-08-21 | 1999-02-16 | Mallinckrodt Group Inc | Estabilizador de hormonas promotoras del crecimiento. |
| GB8826429D0 (en) | 1988-11-11 | 1988-12-14 | Univ Leeds Ind Service Ltd | Enzyme stabilisation systems |
| JP3064413B2 (ja) | 1989-08-15 | 2000-07-12 | マサチユセツツ・インスチチユート・オブ・テクノロジー | 安定化ワクチン組成物 |
| CA2051092C (en) | 1990-09-12 | 2002-07-23 | Stephen A. Livesey | Method and apparatus for cryopreparation, dry stabilization and rehydration of biological suspensions |
| ZA936095B (en) | 1992-08-21 | 1994-03-14 | Univ Melbourne | Cytokine applications. |
| WO1995011700A1 (en) * | 1993-10-29 | 1995-05-04 | Pharmos Corp. | Submicron emulsions as vaccine adjuvants |
| DK1516628T3 (da) | 1995-07-27 | 2013-09-08 | Genentech Inc | Stabil, isotonisk lyofiliseret proteinformulering |
| GB9521806D0 (en) | 1995-10-25 | 1996-01-03 | Cortecs Ltd | Preservation methods |
| FR2746109B1 (fr) | 1996-03-12 | 1998-04-17 | Rhone Poulenc Rorer Sa | Milieu pour la conservation de materiel biologique |
| AU707186B2 (en) | 1997-07-01 | 1999-07-01 | Transgene S.A. | Compositions useful for transferring therapeutically active substances into a target cell, and their use in gene therapy |
| EP1032647B1 (en) | 1997-11-26 | 2006-03-29 | Universal Preservation Technologies, Inc. | Preservation of sensitive biological samples by vitrification |
| EP1133316B1 (en) | 1998-11-16 | 2009-01-21 | Introgen Therapeutics, Inc. | Formulation of adenovirus for gene therapy |
| US6689600B1 (en) | 1998-11-16 | 2004-02-10 | Introgen Therapeutics, Inc. | Formulation of adenovirus for gene therapy |
| AUPQ347199A0 (en) | 1999-10-15 | 1999-11-11 | Csl Limited | Novel polypeptide fragments |
| KR20030020294A (ko) * | 2000-06-08 | 2003-03-08 | 파우더젝트 백신, 인코포레이티드 | 분말 조성물 |
| DE10041515A1 (de) | 2000-08-24 | 2002-03-14 | Gerold Schuler | Verfahren zur Herstellung gebrauchsfertiger, Antigen-beladener oder -unbeladener, kryokonservierter reifer dendritischer Zellen |
| US20040110267A1 (en) | 2000-12-15 | 2004-06-10 | Stratagene | Room temperature stable competent cells |
| US7229645B2 (en) | 2001-06-08 | 2007-06-12 | Powderject Research Limited | Spray freeze-dried compositions |
| US7101693B2 (en) | 2001-09-07 | 2006-09-05 | Brigham Young University | Plasticized hydrophilic glasses for improved stabilization of biological agents |
| JP4936618B2 (ja) | 2001-09-21 | 2012-05-23 | 株式会社ノエビア | 微細エマルション組成物 |
| US20040161776A1 (en) * | 2001-10-23 | 2004-08-19 | Maddon Paul J. | PSMA formulations and uses thereof |
| EP3210624A1 (en) | 2002-02-27 | 2017-08-30 | Immunex Corporation | Stabilized tnfr-fc composition comprising arginine |
| WO2004002534A1 (en) | 2002-06-27 | 2004-01-08 | Novo Nordisk A/S | Use of dimethyl sulfone as isotonicity agent |
| EP1523563A2 (en) | 2002-07-10 | 2005-04-20 | Transgene S.A. | Modified adenoviral fiber with ablated to cellular receptors |
| WO2004035818A1 (en) | 2002-10-21 | 2004-04-29 | Biotage Ab | Use of osmolytes to heat stabilise luciferase and/or apyrase |
| MXPA05006147A (es) | 2002-12-10 | 2005-08-26 | Schering Plough Ltd | Ligando del activador del receptor de nf-kb de canino, y metodos para preparar y usar el mismo. |
| US20060247167A1 (en) | 2003-09-01 | 2006-11-02 | Novo Nordisk A/S | Stable formulations of peptides |
| US7642077B2 (en) | 2003-12-08 | 2010-01-05 | Genencor International, Inc. | Biocomposite comprising co-precipitate of enzyme, silicate and polyamine |
| US20070111211A1 (en) | 2003-12-30 | 2007-05-17 | Virumar Pituach Tarkivim Ltd. | Integrated viral complexes, methods of production thereof, vaccines containing same and methods of use thereof |
| WO2005120546A2 (en) | 2004-03-03 | 2005-12-22 | Essentia Biosystems, Inc. | Compositions and methods for topical diagnostic and therapeutic transport |
| US20060058238A1 (en) | 2004-09-15 | 2006-03-16 | Lee Laurent-Applegate | Fetal skin cell protein compositions for the treatment of skin conditions, disorders or diseases and methods of making and using the same |
| KR101506925B1 (ko) | 2004-10-01 | 2015-03-30 | 램스코르 인코포레이티드 | 편리하게 이식가능한 서방형 약물 조성물 |
| PA8661401A1 (es) | 2005-01-28 | 2006-09-08 | Wyeth Corp | Formulaciones del liquido polipeptido estabilizado |
| GB0502661D0 (en) | 2005-02-09 | 2005-03-16 | Stabilitech Ltd | A desiccated product |
| TWI398272B (zh) | 2005-03-08 | 2013-06-11 | Intervet Int Bv | 化學定義的安定劑 |
| CA2602434C (en) | 2005-04-08 | 2016-06-07 | Argos Therapeutics, Inc. | Dendritic cell compositions and methods |
| US20090155351A1 (en) | 2005-10-04 | 2009-06-18 | Alk-Abello A/S | Solid Vaccine Formulation |
| KR101357685B1 (ko) | 2005-11-21 | 2014-02-06 | 사노피 파스퇴르 리미티드 / 사노피 파스퇴르 리미떼 | 재조합 바이러스용 안정화 제형 |
| JP4394724B2 (ja) | 2005-11-30 | 2010-01-06 | 株式会社癌免疫研究所 | 新規ペプチド化合物 |
| JP5806444B2 (ja) | 2005-12-02 | 2015-11-10 | ノバルティス アーゲー | 免疫原性組成物で使用するためのナノ粒子 |
| EP1987067A4 (en) | 2006-02-15 | 2012-01-25 | Imclone Llc | ANTIBODY FORMULATION |
| ES2286951B1 (es) * | 2006-05-26 | 2008-10-01 | Instituto Cientifico Y Tecnologico De Navarra, S.A | Nanoparticulas bioadhesivas para la administracion de moleculas biologicamente activas. |
| US20090047255A1 (en) | 2006-11-03 | 2009-02-19 | Alphavax, Inc. | Alphavirus and Alphavirus Replicon Particle Formulations and Methods |
| GB0705245D0 (en) | 2007-03-19 | 2007-04-25 | Stabilitech Ltd | Stable biological products |
| DK2131857T3 (en) | 2007-03-22 | 2015-09-14 | Univ Colorado Regents | A method of producing an immunologically active adjuvansbundet dried vaccine composition |
| US7879805B2 (en) | 2007-06-01 | 2011-02-01 | Acologix, Inc. | High temperature stable peptide formulation |
| US20090029463A1 (en) * | 2007-07-25 | 2009-01-29 | Bioe, Inc. | Differentiation of Multi-Lineage Progenitor Cells to Chondrocytes |
| US20090123436A1 (en) | 2007-11-08 | 2009-05-14 | Surmodics, Inc. | Cryopreservative compositions and methods |
| GB2479069B (en) | 2008-09-24 | 2012-07-25 | Stabilitech Ltd | Method for preserving polypeptides using a sugar and polyethyleneimine |
| US20110212127A1 (en) | 2008-09-24 | 2011-09-01 | Stabilitech Ltd. | Method for Preserving Polypeptides Using a Sugar and Polyethyleneimine |
| CN101670104A (zh) | 2009-09-24 | 2010-03-17 | 浙江大学 | 一种含人参皂甙的油佐剂及其制备方法 |
| CN102892424B (zh) | 2010-03-31 | 2015-04-01 | 稳定性科技有限公司 | 病毒颗粒的稳定 |
-
2011
- 2011-03-31 KR KR1020127028370A patent/KR101819250B1/ko not_active Expired - Fee Related
- 2011-03-31 BR BR112012025044A patent/BR112012025044A2/pt not_active Application Discontinuation
- 2011-03-31 DK DK11712653.2T patent/DK2552410T3/en active
- 2011-03-31 US US13/637,828 patent/US9101607B2/en active Active
- 2011-03-31 ES ES11712653T patent/ES2708989T3/es active Active
- 2011-03-31 CN CN201180014386.6A patent/CN102892409B/zh not_active Expired - Fee Related
- 2011-03-31 EP EP11712653.2A patent/EP2552410B1/en active Active
- 2011-03-31 HU HUE11712653A patent/HUE042330T2/hu unknown
- 2011-03-31 GB GB1216472.9A patent/GB2499480A/en not_active Withdrawn
- 2011-03-31 CA CA2795050A patent/CA2795050C/en active Active
- 2011-03-31 WO PCT/GB2011/000497 patent/WO2011121305A2/en not_active Ceased
- 2011-03-31 AU AU2011234268A patent/AU2011234268B2/en not_active Ceased
- 2011-03-31 JP JP2013501932A patent/JP6023696B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2013523705A5 (cg-RX-API-DMAC7.html) | ||
| JP2013523704A5 (cg-RX-API-DMAC7.html) | ||
| EA201400679A1 (ru) | Композиция сухого порошка производного азола для ингаляции | |
| AR089578A1 (es) | Composiciones, metodos para tratar el virus de la hepatitis c y proceso de preparacion | |
| WO2013177172A3 (en) | Herpesvirus compositions and related methods | |
| RU2013121788A (ru) | Ингибиторы репликации вич | |
| PE20140845A1 (es) | Formulaciones parenterales de vacunas contra los norovirus | |
| RU2015118581A (ru) | Лиофилизированные препараты мелфалана флуфенамида | |
| NZ630219A (en) | Lyophilization of synthetic liposomal pulmonary surfactant | |
| RU2015136849A (ru) | Композиции, содержащие 15-он эпк, и способы их применения | |
| IL273685B1 (en) | Immunogens and vaccines containing o25b antigens | |
| AR090592A1 (es) | Sales de 5-[(1r)-2-({2-[4-(2,2-difluoro-2-feniletoxi)fenil]etil}amino)-1-hidroxietil]-8-hidroxiquinolin-2(1h)-ona | |
| JP6023696B2 (ja) | ミョウバンアジュバントおよびミョウバンアジュバント化ワクチンの保存方法 | |
| JP2016506905A5 (cg-RX-API-DMAC7.html) | ||
| CN106063933A (zh) | 通用疫苗冻干保护剂及其应用 | |
| PE20100365A1 (es) | Novedosas vacunas de combinacion con tos ferina de celulas enteras y metodo para su elaboracion | |
| AR088907A1 (es) | Vacuna | |
| RU2016136327A (ru) | Композиции на основе мелатонина для парентерального введения | |
| JP6235614B2 (ja) | 注射用ｈｐｐｈ凍結乾燥粉末注射剤およびその製造方法 | |
| JP2018538308A5 (cg-RX-API-DMAC7.html) | ||
| WO2009150281A1 (es) | Empleo de lauril galato en la prevención y tratamiento de infecciones causadas por el virus de la peste porcina africana (vppa) | |
| BR112016006989A2 (pt) | Formulação imunogênica, uso de uma formulação imunogênica e vacina contra hmpv | |
| JP2016534062A5 (cg-RX-API-DMAC7.html) | ||
| RU2016115374A (ru) | Фармацевтические композиции, содержащие антибактериальные агенты | |
| RU2016101248A (ru) | Лиофилизированные препараты бендамустина гидрохлорида |